Medical Imaging Software Market SWOT Analysis, Dynamics, Drivers, Key Indicators and Forecast to 2022-2030

 

Medical Imaging Software Market Highlights

The medical Imaging software market is projected to reach USD 2,899.61 Million by 2030 at 7.60% CAGR during the forecast period 2022-2030. Medical imaging software supports processing and producing high-resolution images of the internal body parts of a human for disease diagnosis and treatment. The emergence of 3D and 4D imaging technologies, increasing the prevalence of geriatric population and subsequent growth in the incidence of cardiac, and neurological diseases including cancer, growing government funding’s for development of medical diagnostics field are some factors that are anticipated to drive the market growth during the assessment period.  Additionally, a rise in the number of diagnostic centres and increased healthcare expenditure is likely to contribute to market growth. As per the data by the Office for National Statistics, in 2016, the gross domestic expenditure on research and development (R&D) was Euro 33.1 billion (USD 35.2 billion) in the UK. However, the high cost of equipment related to clinical validation and lack of skilled professionals may hamper the market growth during the assessment period.

Regional Analysis

On a regional basis, the Americas is anticipated to dominate the global medical imaging software market report owing to the growing clinical R&D budgets by both governments as well as public and private organizations in diagnostic imaging modalities and increasing adoption of advanced technologies in the region.  Additionally, the rising prevalence of geriatric population along with various chronic diseases is contributing to the growth of this market. According to a report by the Population Reference Bureau, the number of older population (aged 65 and above) will rise to nearly 24% from 15% by 2060. Europe is expected to hold the second largest position in the global medical imaging software market owing to the presence of strong academic & research base and availability of funding for research in the European countries.

Moreover, the rising number of diagnostics centres, strong healthcare infrastructure and awareness among people for detection of diseases is boosting the market in this region. The Asia-Pacific region is anticipated to be the fastest growing region is due to rising demand for technologically advanced software solutions, good quality healthcare infrastructure and incidence of major key players for growth and development in this region. The Middle East & Africa is expected to contribute the least share of the global medical imaging software market. Moreover, the Middle East & Africa region will provide strong opportunities for medical imaging software market due to the rising government initiatives for the healthcare sector.
Segmentation

The global medical imaging software market has been segmented into software type, imaging type, modality, application, and end user

By software type, the market has been segmented into integrated software and stand-alone software.

Based on imaging type, the global medical imaging software market has been segmented into 2D imaging, 3D imaging, and 4D imaging.

Based on modality, the market has been segmented into Computed Tomography (CT), MRI (Magnetic Resonance Imaging), radiography, photoacoustic imaging, nuclear medicine, echocardiography, ultrasound, thermography, and others.

Based on application, the market has been segmented into neurology, cardiology, oncology, musculoskeletal, dental, obstetrics & gynaecology, urology & nephrology, and others.

The global medical imaging software market, by end user, has been segmented into clinics & hospitals, diagnostic centres, research laboratories, and others.

Key Players

The global medical imaging software market players are GE Healthcare, Siemens Healthineers, Agfa-Gevaert N.V., Hologic Inc., Pie Medical Imaging, Media Cybernetics, Inc., AQUILAB, MIM Software Inc., Merge Healthcare Incorporated, ScienceSoft USA Corporation, Acuo Technologies, Fujifilm Holding Company, IBM Corporation, and others.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: sales@marketresearchfuture.com

Comments

Post a Comment

Popular posts from this blog

Macrolide Antibiotics Market Competitive Landscape, Future Plans and Global Trends by Forecast 2030

  Macrolide Antibiotics Market Highlights Macrolides such as azithromycin, clarithromycin, and erythromycin are a class of antibiotics that inhibit protein synthesis. It acts as a bacteriostatic agent against many strains of corynebacterial, listeria, moxicella, streptococci, Neisseria meningitides, Staphylococci, Clostridia, and Haemophilus sp. It is used for the treatment of bacterial infections, such as nose, ear, and throat infections, chest infections, skin infections as well as mouth and dental infections. They are also used as an alternative to penicillin. The global macrolide antibiotics market is expected to show a sharp growth over the forecast period owing to an increasing demand for macrolide across the globe. Rising prevalence of bacterial skin infections and rising number of dermatology clinics also favour the market growth.  According to a study published in the Journal of the American College of Cardiology, macrolide antibiotics may increase the ...
Read more

Atorvastatin API Market Competitive Landscape, Future Plans and Global Trends by Forecast 2030

  Atorvastatin API Market Highlights The hypercholesterolemia segment is expected to lead the market and register a substantial CAGR to reach USD 2,10,753.23 thousand by the end of 2023. High prevalence of hypercholesterolemia is expected to drive the market growth. Additionally, the segment is projected to exhibit the highest CAGR of 4.09% from 2018 to 2023. The atorvastatin API market is anticipated to reach USD 2,852.3 Million by 2030 at 7.50% CAGR during the forecast period 2022-2030. North America accounted for the largest market share of 40.64% in 2017, and the regional market is projected to register a CAGR of 3.10% during the forecast period. Asia-Pacific is expected to register the fastest CAGR. The Chinese market is projected to exhibit the highest growth rate of 5.86% during the forecast period from 2022 to 2030. Atorvastatin API Market Segmentation The atorvastatin API market report has been studied extensively by MRFR experts, with respect to applications. ...
Read more

Nutrigenomics Market | Global Analysis, Statistics, Revenue, Demand and Trend Analysis Research Report by 2030

Market Highlights Following the analysis of the latest trends across the globe, Market Research Future (MRFR) states that the nutrigenomics market is projected to reach the valuation of  USD 464.76 Million by 2030 . In addition, the market is expected to surge at a growth rate of  15.70% during the forecast period ( 2022-2030 ). The Nutrigenomics market is one that has emerged in the past few years, carrying with it a massive potential. With the global statistics for obesity, lifestyle diseases and the ever-increasing demand for effective cosmetic treatments, nutrigenics has risen up as a potential treatment option. Growth Drivers and Key Restraints The boost in the awareness levels among consumers coupled with the rising prevalence of obesity across the globe is predicted to be a crucial factor elevating the market position of nutrigenomics. The surging trend of personalized diet, particularly among athletes will also be beneficial for the market in the near future. ...
Read more